Pinealon 10mg

Quickstart Highlights

Pinealon (also known as EDR; sequence Glu‑Asp‑Arg) is an ultrashort tripeptide investigated for neuroprotective and epigenetic regulatory effects, with most peer‑reviewed data from in vitro and animal studies and limited human observations[1][2][3][4][5]. Published literature frequently describes oral administration in clinical contexts; subcutaneous (SC) human dosing is not established and the SC framework below is educational for research settings only[4][5].

Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
Research-use daily range (educational): 200–500 mcg once daily with gradual titration (SC route not defined in clinical trials; see Evidence note above).
Insulin‑syringe math: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: store at −20 °C (−4 °F) protected from light; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); minimize freeze–thaw cycles[12][13]. Open source

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~6.67 mg/mL)

Week	Daily Dose (mcg)	Units (per injection) (mL)
Weeks 1–2	200 mcg (0.20 mg)	3 units (0.03 mL)
Weeks 3–4	300 mcg (0.30 mg)	4.5 units (0.045 mL)
Weeks 5–6	400 mcg (0.40 mg)	6 units (0.06 mL)
Weeks 7–12	500 mcg (0.50 mg)	7.5 units (0.075 mL)

Route & frequency: Once‑daily subcutaneous (research framework). Evidence note: Peer‑reviewed reports most often describe oral administration in human contexts; subcutaneous human dosing for Pinealon is not established in clinical trials[4][5].
Measuring note: For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

Reference-derived details for Pinealon 10mg.

Draw 3.0 mL bacteriostatic water with a sterile syringe.
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light[12][13]. Open source

Supplies Needed

Planning for 8–16 weeks of once‑daily administration (research framework).

Peptide Vials (Pinealon, 20 mg each):
Peptide Vials (Pinealon, 20 mg each):: 8 weeks ≈ 1 vial (≈19.6 mg total)
Peptide Vials (Pinealon, 20 mg each):: 12 weeks ≈ 2 vials (≈33.6 mg total)
Peptide Vials (Pinealon, 20 mg each):: 16 weeks ≈ 3 vials (≈47.6 mg total)
Insulin Syringes (U‑100):
Insulin Syringes (U‑100):: Per week: 7 syringes (1/day)
Insulin Syringes (U‑100):: 8 weeks: 56 syringes
Insulin Syringes (U‑100):: 12 weeks: 84 syringes
Insulin Syringes (U‑100):: 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial.
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial.: 8 weeks (1 vial): 3 mL → 1 × 10 mL bottle
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial.: 12 weeks (2 vials): 6 mL → 1 × 10 mL bottle
Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial.: 16 weeks (3 vials): 9 mL → 1 × 10 mL bottle
Alcohol Swabs: One for the vial stopper + one for the injection site each day.
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Protocol Overview

Cautious, research‑only framework reflecting current evidence limitations.

Goal: Study neuroprotective and stress‑response pathways influenced by EDR/Pinealon[1][3][5]. Open source
Schedule: Once‑daily subcutaneous injections for 8–12 weeks (optional extension to 16 weeks); note oral dosing dominates human literature[4][5]. Open source
Dose Range: 200–500 mcg daily with gradual titration (educational; not derived from SC clinical trials).
Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for clear syringe conversions.
Storage: Lyophilized at −20 °C (−4 °F); reconstituted at 2–8 °C (35.6–46.4 °F); avoid repeated freeze–thaw[12][13]. Open source

Dosing Protocol

Suggested titration for measurement practice and exposure control (research‑only).

Start: 200–300 mcg daily; increase by ~100 mcg every 1–2 weeks as tolerated.
Target: 400–500 mcg daily by Weeks 5–12.
Frequency: Once per day (subcutaneous).
Cycle Length: 8–12 weeks; optional extension to 16 weeks.
Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions.
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); aliquot if needed and avoid freeze–thaw[12][13]. Open source
Let vials reach room temperature before opening to reduce condensation uptake.

Important Notes

Evidence remains preliminary, with limited human data and predominant oral administration in reports. SC dosing parameters are not clinically established for Pinealon[4][5].

Use new sterile insulin syringes; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation for consistency.

How This Works

EDR/Pinealon may interact with chromatin and regulatory elements, modulating gene expression relevant to neuronal stress responses and plasticity; experimental models show antioxidant effects and preservation of dendritic spines[1][3][5][6][7]. Animal and cellular studies report improved viability under oxidative stress and cognitive/behavioral signals after exposure[1][2].

Lifestyle Factors

Complementary strategies for rigorous research protocols.

Standardize sleep/wake windows and minimize confounders (caffeine/alcohol) when studying cognition.
Maintain consistent nutrition and training plans to reduce variability.
Track outcomes with validated tools (e.g., reaction time, memory tasks) pre/post exposure.

Potential Benefits & Side Effects

Observations from preclinical and review literature.

Neuroprotective and anti‑oxidative signals in vitro and in vivo models[1][2]. Open source
Epigenetic modulation and preservation of neuronal structures (spines/synapses) in models[5][6][7]. Open source
Human evidence remains limited and heterogeneous; safety/tolerability for SC use is not characterized in controlled trials[4][5]. Open source
Subcutaneous injections may cause mild local reactions (redness/itch); rotate sites to avoid lipohypertrophy[8][11]. Open source

Injection Technique

General subcutaneous guidance from authoritative resources[8][9][10][11].

Clean the vial stopper and skin with alcohol; allow to dry.
Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[8]. Open source
Aspiration is not recommended for routine subcutaneous vaccine‑type injections[9][11]. Open source
Rotate sites (abdomen, thighs, upper arms) to prevent lipohypertrophy and ensure consistent absorption[10]. Open source

Recommended Source

We recommend Prime Lab Peptides for high‑purity Pinealon (20 mg).

High‑purity, third‑party‑tested lots with batch COAs.
Consistent, ISO‑aligned handling and documentation.
Cold‑chain conscientious fulfillment.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References